ImmuPharma (GB:IMM) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
ImmuPharma PLC has announced a significant change in share ownership, with Lanstead Capital Investors LP’s voting rights crossing a threshold on August 2, 2024, resulting in their total voting rights in the company dropping from 12.99% to 9.99%. This financial movement was formally notified to the company and the relevant authorities on August 6, 2024.
For further insights into GB:IMM stock, check out TipRanks’ Stock Analysis page.
